CTOR · Company research
Citius Oncology, Inc. Common Stock (CTOR): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 0.851 | $113,284,974.6 | 96721269.60 | 5.9985714285714286 | — | — | 15.9439596959802803 | 2.8051254532809885 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.